UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ...

The 1st UCB Golf Tournament 2025' came to a successful conclusion with a grand Closing and Prize Distribution Ceremony recently (24th January 2025) held on at the prestigious Shaheen Golf and Country ...

1 Day NAMS 1.72% DJIA -0.32% S&P Mid Cap 400 -0.08% Health Care/Life Sciences -0.52% ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...

NEW DELHI: India is bracing for possible disruptions to its pharmaceutical industry - where the American market accounts for almost a third of exports - during Donald Trump’s presidency.

DD reports a patent for KLHL11 pending, a patent for LUZP4 pending, and a patent for CAVIN4 pending, has consulted for UCB, Astellas, Argenx, Immunovant and Arialys pharmaceuticals (all compensation ...

HOUSTON and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with ...

WEST LAFAYETTE, Ind. — Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ...

SAN FRANCISCO, Jan 16 (Reuters) - The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for president-elect Donald Trump and Congress on ...

Belgian drugmaker UCB (Euronext: UCB) has presented what it calls its ... All the news that moves the needle in pharma and biotech Exclusive features, podcasts, interviews, data analyses and ...

Feb. 10, 2025 — Rapid weight loss affects muscle mass and can increase the risk of osteoporosis. But now there is good news for people taking weight loss medication who may be at risk. A new ...